| GTO ID | GTC3822 |
| Trial ID | NCT06339255 |
| Disease | Diffuse Low Grade B-Cell Lymphoma | Primary Mediastinal Large B-Cell Lymphoma | Mantle Cell Lymphoma | Follicular Lymphoma |
| Therapy | CAR-T cell |
| Treatment | CAR-T cells |
| Recruitment status | Recruiting |
| Title | A Multicenter Prospective Observational Study on Chimeric Antigen Receptor (CAR) T-cell Therapy for Lymphoma: Monitoring Feasibility, Efficacy, Toxicity and Biomarkers in a Real Life Setting |
| Year | 2019 |
| Country | Italy |
| Company sponsor | Paolo Corradini |
| Other ID(s) | INT 180/19 |
| Cohort 1 | |||||||
|
|||||||